ESC Premium Access

Questions and answers

Congress Presentation

6 more presentations in this session

Welcome and opening remarks

Speaker: Professor D. McGuire (Dallas, US)


What is the role for SGLT2is for patients with heart failure? A cardiologist’s view

Speaker: Professor G. Filippatos (Athens, GR)


SGLT2 Inhibitors - Diabetes or renal drugs?

Speaker: Professor P. Groop (Helsinki, FI)


Ertugliflozin and the VERTIS program – What have we learned to date?

Speaker: Professor L. Leiter (Toronto, CA)


Bringing forward the future of SGLT2 inhibitors in the treatment of patients with diabetes and cardiovascular disease - A roundtable dscussion

Speaker: Professor D. McGuire (Dallas, US) Professor L. Leiter (Toronto, CA) Professor G. Filippatos (Athens, GR) Professor P. Groop (Helsinki, FI)


Access the full session

Evidence-based treatment of patients with SGLT-2is - What do we know and what is missing?

Speakers: Professor D. McGuire, Professor G. Filippatos, Professor P. Groop, Professor L. Leiter, Professor D. McGuire...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb